EP3494966

IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    13.3.2014
  • EP published:
    3.4.2024
  • EP application number:
    18192279.0
  • Max expiry date:
    12.3.2034
  • Title in English:
    IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION
  • Language of the patent:
    English

Timeline

Today
13.3.2014EP application
3.4.2024EP Publication

Owner

  • Name:
    onCOUR Pharma, Inc.
  • Address:
    2215 Sanders Road Suite 428, Northbrook, IL 60062, US

Inventor

  • Name:
    KING, Nicholas
  • Address:
    Petersham, New South Wales 2049, AU
  • Name:
    GETTS, Daniel
  • Address:
    Washington, District of Columbia 20018, US

Priority

  • Number:
    201361779182 P
  • Date:
    13.3.2013
  • Country:
    US
  • Number:
    201361844961 P
  • Date:
    11.7.2013
  • Country:
    US
  • Number:
    201361865392 P
  • Date:
    13.8.2013
  • Country:
    US
  • Number:
    201361887212 P
  • Date:
    4.10.2013
  • Country:
    US

Classification

  • Categories:
    A61K 9/00, A61K 39/39, A61K 39/00, A61K 31/01, A61K 31/74, A61K 31/765, A61K 31/78, G01N 33/68, A61P 1/04, A61P 3/10, A61P 5/50, A61P 7/02, A61P 9/00, A61P 9/08, A61P 11/02, A61P 11/06, A61P 17/00, A61P 17/04, A61P 17/06

Upload documents